Agreement to develop assays to assist pre-eclampsia diagnosis
Siemens Healthcare Diagnostics has entered into a global licensing agreement with Nephromics to develop two assays to be used as an aid in the diagnosis of pre-eclampsia, a condition that is potentially life-threatening and occurs during pregnancy affecting both the mother and the unborn child. The assays are being developed for the detection of two biomarkers, soluble fms-like tyrosine-kinase-1 (SFLT-1) and placental growth factor (PLGF), which clinical studies have shown to provide early identification of patients with pre-eclampsia.
|
At the forefront of new blood and transplant developments
The NHS Blood and Transplant (NHSBT) Advanced Therapy Unit in Liverpool has been granted a Manufacturers' Authorisation for the production of cell and tissue-based Investigational Medicinal Products (IMP) for clinical trials. This authorisation, granted by the Medicines and Healthcare products Regulatory Authority (MHRA), opens the way for NHSBT to work with the regenerative medicine industry to take innovative cell and tissue therapies to the clinic. NHSBT's specialist production facilities include 32 clean rooms, staffed by trained and experienced scientists.
|
Overnight DNA sequencing service
Source BioScience, the international diagnostics and genetic analysis business, has extended the reach of its superfast DNA sequencing and data analysis service in the UK with the launch of its Overnight Service in Oxford. This will be available to research teams in and around Oxford, with customers receiving their sequencing results by 9.00 am the next day, including Saturdays, at no extra cost.
|
High-performance detectors improve scientific imaging
Scientific imaging will be given a boost by a new company spun out from the University of Oxford. Oxford Imaging Detectors, which is developing high-performance scientific imaging detectors capable of studying structures and processes at the atomic level, has been set up by the university’s technology transfer company, Isis Innovation.
|
Award for mobile metagenome researcher
Thermo Fisher Scientific has announced that the 2011 Oxoid W H Pierce Memorial Prize, which commemorates the late W H (Bill) Pierce, has been awarded to Dr Brian Jones, senior lecturer at the University of Brighton. The award acknowledges Dr Jones’ research into the human gut mobile metagenome, the mobile genetic elements (such as plasmids) that are associated with intestinal microbiota.
|
Life sciences and healthcare to India
Life sciences and healthcare companies across the UK are being urged to sign up to a brand new service to boost their export success to India, a country where biotechnology alone is predicted to be worth £6 billion by 2015. The new service is being offered by the UK India Business Council (UKIBC), the business-led organisation backed by UK Trade & Investment (UKTI) to boost UK-India bilateral trade. For a fee of £35 per month, UKIBC provides intelligence, events, reports, and creates ‘communities’ linking large and small companies in subsectors including medical equipment and technology, healthcare infrastructure, biotechnology, eHealth, pharmaceuticals, training and R&D in India. Online, the members’ life sciences and healthcare sector page will be updated regularly with new reports and analysis.
|